The late-breaking oral session at the European Hematology Association (EHA) 2024 Congress featured new data from abstracts ...
Mohamad Mohty, MD, PhD, of Saint-Antoine Hospital and Sorbonne University, highlights how immunotherapies are offering various effective treatment options for patients with multiple myeloma and ...
Joseph Mikhael, MD, MEd, FRCPC, FACP, of the International Myeloma Foundation, HonorHealth, and TGen, notes that US physicians have more flexibility when treating patients with early ...
Notably, adolescents and young adults (AYA) living with type 1 diabetes (T1D) who reported more comfort with self-management ...
It’s important for clinicians to listen to patients and know how heart disease may affect women differently than men, said Kathryn Lindley, MD, FACC, Vanderbilt University Medical Center.
At a session of the European Hematology Association 2024 Congress, presenters shared updates from trials of treatment ...
Jennifer Vidrine, MBBS, MRCP, of Newcastle upon Tyne Hospitals, stresses the importance of providing personalized, beneficial end-of-life care for patients with hematologic diseases.
At a friendly debate held at the European Hematology Association 2024 Congress, hemophilia experts argued for and against ...
Ryan Jacobs, MD, of Atrium Health Levine Cancer Institute, explains that the phase 2 CAPTIVATE study's fixed-duration treatment cohort shows long-term progression-free survival for patients with ...
Investigators from Germany conducted a systematic review of different MRI features in soft tissue sarcoma (STS) that are used ...
Heidi Crayton, MD, and Maria Lopes, MD, discuss the impact of multiple sclerosis on patients, families, and caregivers, ...
Heidi Crayton, MD, and Maria Lopes, MD, discuss the limitations of using relapse rates as a critical endpoint in trials for ...